A great deal of effort has been expended on studying the biological mechanisms of TACC3 over-expression in cancers (Stewart et al., 2004; Lauffart et al., 2005; Wang et al., 2011; Singh et al., 2012; Ha et al., 2015; Du et al., 2016; Li et al., 2017; Matsuda et al., 2018). Here, TACC3 is linked to cancer.